UNSPSC 51191564: Quinethazone

This classification denotes a thiazide diuretic with the molecular formula C10H12ClN3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 455E0S048W, chemically known as 7-chloro-2-ethyl-6-sulfamoyl-1,2,3,4-tetrahydro-4-quinazolinone but generally known as quinethazone, which bears US NIH Compound Identifier 6307. European Medicines Agency schedules Quinethazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10213MIG.

UNSPSC 51191564 Quinethazone, a Commodity code, does not align with the recent state and local solicitations tagged under it. The three most recent opportunities — a Broward County, Florida RFI for DeZurik/APCO industrial valves and repair services for wastewater treatment; a Washington State Department of Corrections RFQQ for parenteral nutrition and intravenous products; and a City of Meriden, Connecticut IFB for sodium bisulfite chemical supply — span industrial water infrastructure, medical pharmaceuticals, and municipal water treatment chemicals, none of which correspond to quinethazone, a diuretic pharmaceutical compound. State and local procurement activity under this UNSPSC code shows little relevant scope alignment between the nominal commodity classification and actual solicitation activity.

The recent opportunities reflect a narrow geographic and issuing-body footprint: Florida county government, Washington state corrections, and a Connecticut municipality. No pattern of repeat buyers or geographic concentration emerges from the three postings. The lack of substantive match between the code's stated product (quinethazone) and the divergent commodities and services appearing in recent solicitations suggests either systemic misclassification in the source data or minimal authentic procurement activity under this specific code designation. No further opportunity detail supports a realistic market assessment for quinethazone itself.